Carbon monoxide binds avidly to hemoglobin after crossing the alveolar-capillary membrane. This rapid removal from plasma helps maintain a concentration gradient between alveolar gas and pulmonary blood, supporting continued uptake during the measurement. The resulting transfer reflects how effectively gas moves from the air spaces into blood rather than simply indicating the amount present in inhaled air.
The alveolar-capillary membrane is the barrier that carbon monoxide must cross before entering pulmonary blood. Its role makes carbon monoxide diffusion sensitive to the efficiency of gas transfer across the lung. When this transfer is impaired, less carbon monoxide is removed from inhaled gas, producing a smaller measured change between inhaled and exhaled concentrations.
A reduced diffusing capacity for carbon monoxide can indicate impaired pulmonary gas exchange. In the medical context, lower values are associated with interstitial lung disease, emphysema, and pulmonary vascular abnormalities. The result therefore provides information about transfer across the lung and can help relate pulmonary function findings to disorders affecting lung tissue or blood vessels.
Testing assesses carbon monoxide uptake by comparing its concentration in inhaled and exhaled gas. The change in concentration indicates how much carbon monoxide was removed from the gas during contact with the lungs and blood. This measurement is reported as the diffusing capacity for carbon monoxide, or DLCO, and is used to evaluate pulmonary gas transfer.
DLCO adds information about gas-transfer efficiency that is not provided by carbon monoxide concentration in inhaled air alone. Because the measurement reflects uptake across the alveolar-capillary interface, it can reveal impaired exchange associated with interstitial lung disease, emphysema, or pulmonary vascular abnormalities. Clinicians can use this functional information alongside other pulmonary findings when assessing lung disorders.
Measuring carbon monoxide diffusion is clinically relevant when evaluation requires information about how efficiently the lungs transfer gas into blood. The test can help identify reduced exchange in conditions such as interstitial lung disease, emphysema, and pulmonary vascular abnormalities. Its value comes from linking a measurable inhaled-to-exhaled gas change with the function of the alveolar-capillary interface.